Stories

Tue, 31 Mar 2026

Tue, 31 Mar 2026 Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.


Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025